Study Conduct

Why is there such inefficiency in site selection?

Thursday, December 15, 2016

This question is often asked about an industry deeply root­ed in paper-based, spreadsheet tools for clinical trial conduct. Study teams have continued to rely on these older tools and relation­ships with principal investigators that have developed over time to select sites, building an institu­tional knowledge about specific sites based on previous studies.

[Read More]

ACRES, BSI collaborate on clinical research sites standards

Tuesday, December 13, 2016

The Alliance for Clinical Research Excellence and Safety (ACRES), in partnership with the British Standards Institution (BSI), has launched a multi-stakeholder global working party to fast-track development of standards for all aspects of site work, laying the foundation for recognizing and rewarding excellence at clinical research sites worldwide and accelerating development of safe and effective new medicines.

[Read More]

Center Point Clinical Services launches site-less CRO

Thursday, December 8, 2016

Center Point Clinical Services, creator of the Clinical Trial Research Pharmacist (CTRP) solution, has launched the world’s first site-less technology CRO. The site-less CRO model is designed to support the evolving world of clinical trials by empowering study sponsors to de-risk the clinical trial process, increase quality, reduce costs and ensure robust data for regulatory submissions.

[Read More]

Report: Vast swathes of human biology untouched by drug discovery programs

Monday, December 5, 2016

Scientists have created a map of all 1,578 licensed drugs and their mechanisms of action—as a means of identifying ‘uncharted waters’ in the search for future treatments. Their analysis of drugs licensed through the FDA reveals that 667 separate proteins in the human body have had drugs developed against them—just an estimated 3.5% of the 20,000 human proteins.

[Read More]